Doseloop Beta

Dapagliflozin

medication

SGLT2 inhibitor (brand name: Farxiga) for type 2 diabetes and heart failure. May have longevity and metabolic benefits.

Reported Benefits

Reported Side Effects

Research (2 studies)

RCT

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.

ClinicalTrials.gov • 2023

Not specified in available data

RCT

The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Patients With T2DM

ClinicalTrials.gov • 2015

Not specified in available data

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 2
Researched benefits 3
Side effects noted 2